Epidermal stem cells play a central role in tissue homeostasis, wound repair, tumor initiation, and gene therapy. A major impediment to the purification and molecular characterization of epidermal stem cells is the lack of a quantitative assay for cells capable of long-term repopulation in vivo, such as exists for hematopoietic cells. The tremendous strides made in the characterization and purification of hematopoietic stem cells have been critically dependent on the availability of competitive transplantation assays, because these assays permit the accurate quantitation of long-term repopulating cells in vivo. We have developed an analogous functional assay for epidermal stem cells, and have measured the frequency of functional epidermal stem cells in interfollicular epidermis. These studies indicate that cells capable of long-term reconstitution of a squamous epithelium reside in the interfollicular epidermis. We find that the frequency of these long-term repopulating cells is 1 in 35,000 total epidermal cells, or in the order of 1 in 10 4 basal epidermal cells, similar to that of hematopoietic stem cells in the bone marrow, and much lower than previously estimated in epidermis. Furthermore, these studies establish a novel functional assay that can be used to validate immunophenotypic markers and enrichment strategies for epidermal stem cells, and to quantify epidermal stem cells in various keratinocyte populations. Thus further studies using this type of assay for epidermis should aid in the progress of cutaneous stem celltargeted gene therapy, and in more basic studies of epidermal stem cell regulation and differentiation.
T
here is considerable evidence for a long-term repopulating cell in the interfollicular epidermis (1) (2) (3) (4) . However, the location of the most primitive stem cell (SC) in terms of production of the interfollicular epidermis is in debate (a follicular vs. interfollicular keratinocyte) (1) (2) (3) (4) (5) (6) (7) (8) . It is thought by many that cutaneous epithelia contain SCs from a common ectodermal origin that are equipotent, albeit located in different niches (4, 6) . One prevailing model of epithelial SC function is that, under steady state conditions, SCs are unipotent (i.e., producing only follicular or only interfollicular epidermis), whereas during regeneration after tissue damage, SCs display multipotency (reviewed in ref. 9 ). Integrity of the epidermis is maintained by division of cells in the proliferative basal layer to replace differentiated cells in the outermost stratum corneum layer that are continuously being lost. SCs in the basal layer divide to produce, on average, one SC and one transit-amplifying cell (10) . The transit-amplifying cells amplify the basal cell population, but are limited to a finite number of cell divisions before they differentiate and are sloughed into the environment (11) . SCs are thought to constitute 1-10% of the basal cell population (1, 2, (12) (13) (14) . However, despite decades of work to characterize the epidermal SC, there still is no standardized quantitative assay to measure it.
We have designed an in vivo assay based on validated functional assays for hematopoietic SCs (15, 16) . When competitive long-term repopulating assays combined with a limiting dilution design were used, SC frequency in the bone marrow was determined to be 1 in 10,000 (17, 18) . This type of assay has become a standard in hematopoiesis for the analysis of SC markers (19, 20) and for studies of SC differentiation and regulation (21) (22) (23) . For competitive repopulation assays, one population, the competitor, serves as a standard for repopulating potential. The second population, the test population, is of unknown hematopoietic SC content. Mixtures of competitor and test marrow cells are injected into lethally irradiated mice, and the presence of peripheral blood leukocytes derived from the test cells is assessed 12-20 weeks after transplant by using distinguishable surface markers (e.g., Ly5.1 vs. Ly5.2) (20, 23) . Using serial dilutions of test cells, a limiting dilution design is used to measure SC frequency. The validity of limiting dilution in competitive repopulating assays is based on the premise that the assay is sensitive enough to detect the progeny of a single SC. The strength of these assays is the long-term functional nature of the repopulation carried out in vivo that allows the distinction between true SCs vs. shorter-term repopulating cells (transitamplifying cells in epidermis), and the ability to quantify SCs by competitive limiting dilution analysis.
Our assay for epidermal SCs exploits the ability of dissociated keratinocytes to reform a cornified stratified epithelium when implanted atop the s.c. fascia of immunodeficient mice (24, 25) . By studying fluorescent keratinocytes in a competitive repopulating assay at limiting dilutions, we have measured the frequency of functional epidermal SCs in interfollicular epidermis. We find that the frequency of these long-term repopulating cells is surprisingly similar to that of hematopoietic SCs in the bone marrow and is much lower than previously estimated.
Methods
Mice. The GFP-expressing mouse, strain, C57BL͞6-TgN(ACTbEGFP)1Osb (The Jackson Laboratory) was used as a source of test keratinocytes. These mice ubiquitously express GFP under the control of the ␤-actin promoter (26) . Keratinocytes from GFP-negative siblings were used as competitor keratinocytes, whereas severe combined immunodeficiency (SCID) mice (Simonsen Laboratories) served as recipients. lar) samples in 0.05% trypsin for 12 min. Varying numbers of GFP-positive keratinocytes were mixed with a fixed number (1 ϫ 10 6 ) of GFP-negative keratinocytes. The cells were pelleted, resuspended in 0.1 ml of keratinocyte growth medium with 0.06 mM Ca to form a cell slurry, and then placed into a 6-mm (internal diameter) silicone chamber (Renner, Dannstadt, Germany) on the fascia of recipient mice (25) .
Chamber Implantation. Mice were anesthetized, and an 0.8-cm area of skin on the back was excised down to the fascia. The chamber, shaped like a top hat with the top cut off (Fig. 1b) , was then implanted and sutured in place. After addition of the keratinocytes, tegaderm (3M) was placed over the chamber for 1 week.
Removal of Resultant Epidermis. For long-term repopulating assays, the chambers were harvested at 5-6 weeks or at 9 weeks. Animals were killed, and the chamber epidermis was excised. For limiting dilution studies, a whole mount was prepared, fixed in 2% paraformaldehyde, and examined under an inverted fluorescence microscope (Leica DM IRB inverted microscope). permeabilized with 0.01% Triton X-100. Primary antibody was rabbit anti-mouse pAb AF109 against keratin 1 (10 g͞ml; Covance, Berkeley, CA). Secondary antibody was goat antirabbit IgG Texas red (Molecular Probes). Nucleated cells were identified with 4Ј,6-diamidino-2-phenylindole.
Results

Reconstitution͞Repopulation of Full-Thickness Murine Epidermis on
the Fascia of SCID Mice. After isolation of interfollicular epidermis (Fig. 1a) , GFP-positive murine keratinocyte test cells compete against competitor GFP-negative murine keratinocytes to reform an epidermis in vivo. These keratinocytes are mixed and seeded in a chamber on the fascia of a GFP-negative mouse recipient (Fig. 1b) . After 2 weeks, a complete epidermis has formed, and chambers are removed at various times after this point to determine, by whole mount microscopy, the presence or absence of GFP-positive cell clusters. We determined that 1,000,000, but not 500,000 or 200,000. keratinocytes are sufficient to consistently produce a complete epidermis in 2 weeks ( Fig. 1 c and d) . Therefore, in subsequent experiments, a fixed number of competitor GFP-negative keratinocytes (1,000,000) were seeded along with variable numbers of test GFP-positive keratinocytes. When GFP-positive keratinocytes alone were implanted, the resultant epidermis was uniformly GFP positive ( Fig. 1 e and f ) .
To exclude the possibility of ingrowth of keratinocytes from adjacent recipient͞host epidermis, implanted chambers were examined for ingrowth over 9 weeks. Ingrowth is unlikely because of the tortuous path required for recipient epidermal keratinocytes to take around the edge of the silicone chamber, and previous studies demonstrated no ingrowth in this type of chamber (25) . There was no ingrowth of host epidermis into empty chambers over 9 weeks, as evidenced by lack of a visible epithelial layer (Fig. 1g) and lack of pancytokeratin immunofluorescence (Fig. 1h) . In addition, when GFP-negative keratinocytes were implanted on GFP-positive mice, no GFP-positive epidermal cells were seen in the chambers over a 4-week period (data not shown).
We also performed a study to determine how well keratinocytes attached to fascia. We compared the number of keratinocytes that attached to the fascia in a chamber in vivo with the number that attached to collagen IV in a chamber in vitro (a substrate used for rapid murine keratinocyte SC attachment; ref. 27 ). When 10 6 cells were implanted in each chamber for 2 h, there was no significant difference between the number of cells that attached to fascia and the number that attached to collagen IV (260,000 Ϯ 61,000 vs. 307,000 Ϯ 56,000, respectively, n ϭ 3). Thus, the fascia appears to be an adequate substrate for keratinocyte attachment.
Large GFP-Positive Competitive Repopulation Units Are Detected in the Chamber Epidermis After 5-9 Weeks. Implantation of small numbers of GFP-positive keratinocytes along with 1,000,000 GFP-negative keratinocytes permitted the visualization of individual competitive repopulation units (Fig. 2) . At 4-9 weeks, GFP-positive keratinocytes present were part of large epidermal units. A crude estimation of the number of cells in a typical cylindrically shaped unit was in the order of 4,000-6,000 cells. Thus, a single GFP-positive competitive repopulation unit was readily discernable in a background of GFP-negative competitor cells. At early time points (e.g., 4 weeks, Fig. 2a ), a few individual GFP-positive stratum corneum cells were seen scattered throughout the reconstituted epidermis, but not at later time points (e.g., 9 weeks). These cells presumably represent more differentiated nonstem keratinocytes that were originally seeded, but that had not yet been sloughed. However, by 4-6 weeks, the earliest time point of examination of these chambers, we did not see small clusters of cells or units only in the upper epidermis. We believe this is because we were looking at too late a time point to observe transit-amplifying cell clones. From these studies we concluded that this method is sufficiently sensitive to detect the progeny of a single SC, a requirement for a valid limiting dilution assay.
SC Frequency in Neonatal Murine Epidermis.
To determine SC frequency in neonatal murine epidermal cells, dilutions of GFP-positive keratinocytes ranging from 3,250 to 50,000 GFPpositive keratinocytes were implanted. At 5 to 6 weeks, resultant epidermis was graded as positive or negative for GFP-positive competitive repopulation unit(s) by fluorescence microscopy of epidermal whole mounts. The three initial experiments were pooled. Reconstitution was achieved with 12,500 GFP-positive test cells but not with 7,500 or fewer. These results lead to a calculated SC frequency of 1 in 30,000 (95% confidence, 1 in 15,000 to 1 in 60,000) ( Table 1 ). The value of the 2 test was not statistically significant in Table 1 (P Ͼ 0.05), demonstrating internal consistency in our assay. Analysis of the data by using an alternate limiting dilution analysis software program, GENMOD procedure in SAS analysis, gave comparable results. The pooling of the data could be justified by the insignificant differences among the three experiments in the generalized linear model with log link when the experiment was a fixed categorical variable in the GENMOD analysis.
A single larger experiment narrowed in on the predicted SC frequency from the initial experiments. The single study (Table  2) was analyzed in a similar fashion, and SC frequency of neonatal murine epidermal cells was 1 in 26,000 (95% confidence limits, 1 in 14,000 to 1 in 51,000), in close agreement with the results of the first pooled study.
Finally, to determine that the assay was measuring a true long-term repopulating cell, rather than a shorter-term transitamplifying cell, we performed the same assay at 9 weeks. SC frequency after 9 weeks of reconstitution was 1 in 41,000 (95% confidence limits, 1 in 72,000 to 1 in 23,000) ( Table 3 ). The P value for difference in SC frequency between weeks 6 and 9 was not significant (P ϭ 0.32 for L-CALC, P ϭ 0.36 for GENMOD).
Furthermore, the data from Table 2 (5-6 weeks) and Table 3 (9 weeks) were combined, resulting in a SC frequency of 1 in 35,000. Combining the data resulted in an insignificant 2 test, confirming the consistency of the data distribution between 5 and 9 weeks.
Basal Cell Density in the Murine Epidermal Cell Population. Previous estimates of epidermal SC frequency used the basal cell as the denominator (1, 2, 12-14). To compare the above results to prior studies, we performed a crude estimate of the basal cell density of neonatal murine epidermis, by determining the proportion of nucleated keratinocytes (4Ј,6-diamidino-2-phenylindole positive) that were keratin 1 negative. Keratin 1 protein is found predominantly in suprabasal cells, although occasional basal cells may be positive (28) . By this method, we found the basal cell density to be 47 Ϯ 4%. Thus, if 1 in 26,000 to 1 in 40,000 keratinocytes is a SC, and 47% are basal cells, then in the order of 0.01% of basal cells are SCs, a frequency similar to that seen in nucleated bone marrow cells, and much less than previously estimated for keratinocyte SCs by other methods.
Discussion
Previous methods of SC analysis in epidermis include short-term in vitro clonogenic assays of human keratinocytes and in vivo studies of label-retaining cells in mice. Clonogenic assays of human keratinocytes in vitro may overestimate SC number, because not all of the cells that generate large colonies may be capable of long-term epidermal regeneration (6) . When mice are serially injected with tritiated thymidine or BrdUrd, almost 100% of the basal cells become labeled. After 30-60 days, there is a pool of cells that still retains label; it is proposed that, because label-retaining cells must be relatively quiescent, they may represent murine epidermal SCs (12) . An inherent limitation of these two types of assays is that they do not directly measure the ability of the cells being studied to functionally recreate an in vivo epidermis. One important question regarding any functional assay for SCs is what duration of repopulation is required to distinguish the true epidermal SC from more short-term repopulating cells. In the epidermis, the short-term repopulating cells are the transitamplifying cells. In murine epidermis, transit time from basal layer to granular layer has been estimated to be 7-10 days (29) . The cell cycle time in mammalian epidermis has been estimated to be 4-5 days (30, 31) . Transit-amplifying cells are expected to go through approximately three divisions (32) before terminally differentiating. However, the SC is a cell considered to be out of step with this general program. There are several lines of evidence suggesting that 30 days of epidermal turnover is an adequate interval for assessing long-term repopulation of skin. In a study examining loss of tritiated thymidine over time in epidermis, 35% of basal cells retained Ͼ45 grains of tritiated thymidine at 1 h, but only 0.2% retained Ͼ45 grains of label at 30 days (33) . Because the cell cycle time of proliferative cells in adult mouse ear is Ϸ4.8 days and may be shorter in a younger growing animal, such cells retaining label at 30 days were cycling markedly out of phase with respect to the rest of the epithelial cells, suggesting that these may be SCs (12) . The number of these label-retaining cells detected at 30 days and at 72 days, was similar, whereas all cells with Ͻ45 grains continued to lose label over time (33) , suggesting that the most primitive SC may be detected at 30 days.
In the case of murine hematopoietic SCs, the intervals used to assess long-term repopulation range from 12 to 20 weeks after transplantation (34) . Assays performed at early time points are thought to overestimate the frequency of SCs, as they would additionally measure the progeny of some short-term repopulating cells. Because the hierarchy of epidermal SC differentiation is poorly understood, we decided to assess long-term repopulation first at 35-42 days (5-6 weeks) and then at 9 weeks. In our studies, the number of repopulating cells detected did not decrease significantly at 9 weeks vs. 5-6 weeks, strongly suggesting that we are measuring the most primitive SC at 5-6 weeks.
The assay, as used in this study, tests only for SCs derived from interfollicular epidermis, and confirms that long-term repopulating cells do in fact reside in this location. It is possible that there may be more numerous and͞or more primitive (capable of longer-term repopulation) SCs located in the follicular bulge (7) . Further studies using follicle-derived keratinocytes vs. interfollicular keratinocytes as test cells in this assay will help clarify these issues.
The assay, as currently designed, measures only the ability of cells to form an epidermis, and hence does not test the pluripotency of these SCs, i.e., their ability to form hair follicles and sebaceous glands. Under appropriate conditions, interfollicular epithelium has been shown to regenerate hair and sebocyte lineages (35) (36) (37) . Only after future studies using this assay to identify the most effective marker(s) for long-term repopulating cells (see below) will we finally be able to test for the multipotency of the long-term repopulating cell that we are measuring in this assay.
Previous estimates of SC frequency in the epidermis, based on quantitative radiobiological experiments, are in the order of 10% of basal cells (ref. 38 ; reviewed in ref. 6 ). Another study suggests that only 4% of the basal cells are SCs (27) . However, as discussed above, only 0.2% of cells continue to retain large amounts of label without significant loss over 30 -72 days (33) .
Because our studies indicate that 47% of neonatal murine epidermal cells are basal cells, and 1 in 26,000 to 1 in 40,000 epidermal cells is a SC, in the order of 0.01% of basal cells are SCs. It is notable that the frequency of epidermal SCs in this assay is similar to the frequency of hematopoietic SCs in the marrow (0.01%). One potential explanation for the much lower than expected frequency of repopulating units measured in this assay is that the fascia might be a suboptimal environment for epidermal SCs. The fact that the murine keratinocytes adhere to fascia as efficiently as to collagen IV is somewhat reassuring. However, it is still theoretically possible that epidermal SCs proliferate less efficiently on fascia than in their natural environment. In this unlikely to be the case, this functional assay would still permit the accurate measurement of the relative repopulating abilities of keratinocytes from different sources.
The concept of an epidermal proliferation unit (reviewed in ref. 39 ) is that of a SC and Ϸ10 surrounding basal cells supplying the epidermal cells above (Ͻ50 cells in total) . This structure appears to be much smaller than the structures observed in our studies and by others (see refs. 3 and 40). In each of these studies, a much larger unit containing hundreds to thousands of cells appears to be supplied by a single cell. In another study, large epidermal units were observed with a hyperproliferative state (41) . To reserve the term epidermal proliferation unit for the organizational structure observed by Potten (42), we have termed the units produced by the long-term repopulating SCs in this assay ''competitive repopulation units,'' a standard term used for hematopoietic SCs.
This study uses competitve repopulation combined with limiting dilution analysis to measure an absolute frequency. However, this type of assay may also be used at nonlimiting dilution to assess the efficiency of various methods of SC isolation. This type of study measures the ''fold improvement'' in the repopulating ability of purified test populations vs. unsorted test cells (20) . A number of methods have been proposed to enrich for epidermal SCs, but controversy exists regarding the best epidermal SC marker (10) . Methods that isolate populations enriched in epidermal SCs include (i) highest levels of ␤1 integrin (43); (ii) high levels of ␣6 integrin in combination with the lack of a transferrin receptor (44) ; and (iii) a Hoechst and propidium iodide dye technique combined with specifically defined gating (45) . This assay provides an in vivo functional assay by which to examine the effectiveness of these isolation techniques in identifying true long-term repopulating cells. Based on the lessons learned concerning hematopoietic SCs, we anticipate that the immunophenotype of epidermal SCs will prove to be complex, and require a number of positive and negative selection markers, which can then be validated by this assay.
In summary, this novel assay has confirmed the existence of a long-term repopulating cell in the interfollicular epidermis, the frequency of which is 1 in 26,000 to 1 in 40,000. This study has established a quantitative in vivo assay for keratinocyte SCs, analogous to that used for hematopoietic SCs. This in vivo functional assay for epidermal SCs, is an important step for SC quantitation of various keratinocyte populations (e.g., aging, development, and disease), for analyzing putative markers for the epidermal SC, for cutaneous SC-targeted gene therapy, and for more basic studies of epidermal SC regulation and differentiation.
